Global Biologics (Biosimilar) Market Report 2019, Competitive Landscape, Trends and Opportunities

1 Biologics (Biosimilar) Market Overview

1.1 Product Overview and Scope of Biologics (Biosimilar)

1.2 Biologics (Biosimilar) Segment by Type

1.2.1 Global Biologics (Biosimilar) Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Recombinant Non-glycosylated Proteins

1.2.3 The Market Profile of Recombinant Glycosylated Proteins

1.3 Global Biologics (Biosimilar) Segment by Application

1.3.1 Biologics (Biosimilar) Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Oncology

1.3.3 The Market Profile of Blood Disorders

1.3.4 The Market Profile of Growth Hormonal Deficiency

1.3.5 The Market Profile of Chronic and Autoimmune Disorders

1.3.6 The Market Profile of Others

1.4 Global Biologics (Biosimilar) Market by Region (2014-2026)

1.4.1 Global Biologics (Biosimilar) Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.3 Europe Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.3.1 Germany Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.3.2 UK Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.3.3 France Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.3.4 Italy Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.3.5 Spain Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.3.6 Russia Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.3.7 Poland Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.4 China Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.5 Japan Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.6 India Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.8 Central and South America Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Biologics (Biosimilar) Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Biologics (Biosimilar) (2014-2026)

1.5.1 Global Biologics (Biosimilar) Revenue Status and Outlook (2014-2026)

1.5.2 Global Biologics (Biosimilar) Production Status and Outlook (2014-2026)

2 Global Biologics (Biosimilar) Market Landscape by Player

2.1 Global Biologics (Biosimilar) Production and Share by Player (2014-2019)

2.2 Global Biologics (Biosimilar) Revenue and Market Share by Player (2014-2019)

2.3 Global Biologics (Biosimilar) Average Price by Player (2014-2019)

2.4 Biologics (Biosimilar) Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Biologics (Biosimilar) Market Competitive Situation and Trends

2.5.1 Biologics (Biosimilar) Market Concentration Rate

2.5.2 Biologics (Biosimilar) Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 CP Guojian Pharmacy

3.1.1 CP Guojian Pharmacy Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.1.3 CP Guojian Pharmacy Biologics (Biosimilar) Market Performance (2014-2019)

3.1.4 CP Guojian Pharmacy Business Overview

3.2 Merck

3.2.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.2.3 Merck Biologics (Biosimilar) Market Performance (2014-2019)

3.2.4 Merck Business Overview

3.3 3sbio

3.3.1 3sbio Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.3.3 3sbio Biologics (Biosimilar) Market Performance (2014-2019)

3.3.4 3sbio Business Overview

3.4 Hospira

3.4.1 Hospira Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.4.3 Hospira Biologics (Biosimilar) Market Performance (2014-2019)

3.4.4 Hospira Business Overview

3.5 Changchun High tech

3.5.1 Changchun High tech Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.5.3 Changchun High tech Biologics (Biosimilar) Market Performance (2014-2019)

3.5.4 Changchun High tech Business Overview

3.6 Pfizer

3.6.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.6.3 Pfizer Biologics (Biosimilar) Market Performance (2014-2019)

3.6.4 Pfizer Business Overview

3.7 Mylan

3.7.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.7.3 Mylan Biologics (Biosimilar) Market Performance (2014-2019)

3.7.4 Mylan Business Overview

3.8 Novartis

3.8.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.8.3 Novartis Biologics (Biosimilar) Market Performance (2014-2019)

3.8.4 Novartis Business Overview

3.9 Sandoz

3.9.1 Sandoz Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.9.3 Sandoz Biologics (Biosimilar) Market Performance (2014-2019)

3.9.4 Sandoz Business Overview

3.10 Sanofi

3.10.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.10.3 Sanofi Biologics (Biosimilar) Market Performance (2014-2019)

3.10.4 Sanofi Business Overview

3.11 Roche

3.11.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.11.3 Roche Biologics (Biosimilar) Market Performance (2014-2019)

3.11.4 Roche Business Overview

3.12 Biotech Pharma

3.12.1 Biotech Pharma Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.12.3 Biotech Pharma Biologics (Biosimilar) Market Performance (2014-2019)

3.12.4 Biotech Pharma Business Overview

3.13 Teva

3.13.1 Teva Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.13.3 Teva Biologics (Biosimilar) Market Performance (2014-2019)

3.13.4 Teva Business Overview

3.14 AbbVie

3.14.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.14.3 AbbVie Biologics (Biosimilar) Market Performance (2014-2019)

3.14.4 AbbVie Business Overview

3.15 Novo Nordisk

3.15.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.15.3 Novo Nordisk Biologics (Biosimilar) Market Performance (2014-2019)

3.15.4 Novo Nordisk Business Overview

3.16 Johnson & Johnson

3.16.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.16.3 Johnson & Johnson Biologics (Biosimilar) Market Performance (2014-2019)

3.16.4 Johnson & Johnson Business Overview

3.17 Lilly

3.17.1 Lilly Basic Information, Manufacturing Base, Sales Area and Competitors

3.17.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.17.3 Lilly Biologics (Biosimilar) Market Performance (2014-2019)

3.17.4 Lilly Business Overview

3.18 Amgen

3.18.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors

3.18.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.18.3 Amgen Biologics (Biosimilar) Market Performance (2014-2019)

3.18.4 Amgen Business Overview

3.19 Gelgen Biopharma

3.19.1 Gelgen Biopharma Basic Information, Manufacturing Base, Sales Area and Competitors

3.19.2 Biologics (Biosimilar) Product Profiles, Application and Specification

3.19.3 Gelgen Biopharma Biologics (Biosimilar) Market Performance (2014-2019)

3.19.4 Gelgen Biopharma Business Overview

4 Global Biologics (Biosimilar) Production, Revenue (Value), Price Trend by Type

4.1 Global Biologics (Biosimilar) Production and Market Share by Type (2014-2019)

4.2 Global Biologics (Biosimilar) Revenue and Market Share by Type (2014-2019)

4.3 Global Biologics (Biosimilar) Price by Type (2014-2019)

4.4 Global Biologics (Biosimilar) Production Growth Rate by Type (2014-2019)

4.4.1 Global Biologics (Biosimilar) Production Growth Rate of Recombinant Non-glycosylated Proteins (2014-2019)

4.4.2 Global Biologics (Biosimilar) Production Growth Rate of Recombinant Glycosylated Proteins (2014-2019)

5 Global Biologics (Biosimilar) Market Analysis by Application

5.1 Global Biologics (Biosimilar) Consumption and Market Share by Application (2014-2019)

5.2 Global Biologics (Biosimilar) Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Biologics (Biosimilar) Consumption Growth Rate of Oncology (2014-2019)

5.2.2 Global Biologics (Biosimilar) Consumption Growth Rate of Blood Disorders (2014-2019)

5.2.3 Global Biologics (Biosimilar) Consumption Growth Rate of Growth Hormonal Deficiency (2014-2019)

5.2.4 Global Biologics (Biosimilar) Consumption Growth Rate of Chronic and Autoimmune Disorders (2014-2019)

5.2.5 Global Biologics (Biosimilar) Consumption Growth Rate of Others (2014-2019)

6 Global Biologics (Biosimilar) Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Biologics (Biosimilar) Consumption by Region (2014-2019)

6.2 United States Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

6.3 Europe Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

6.4 China Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

6.5 Japan Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

6.6 India Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

7 Global Biologics (Biosimilar) Production, Revenue (Value) by Region (2014-2019)

7.1 Global Biologics (Biosimilar) Production and Market Share by Region (2014-2019)

7.2 Global Biologics (Biosimilar) Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

8 Biologics (Biosimilar) Manufacturing Analysis

8.1 Biologics (Biosimilar) Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Biologics (Biosimilar)

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Biologics (Biosimilar) Industrial Chain Analysis

9.2 Raw Materials Sources of Biologics (Biosimilar) Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Biologics (Biosimilar)

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter’s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Biologics (Biosimilar) Market Forecast (2019-2026)

11.1 Global Biologics (Biosimilar) Production, Revenue Forecast (2019-2026)

11.1.1 Global Biologics (Biosimilar) Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Biologics (Biosimilar) Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Biologics (Biosimilar) Price and Trend Forecast (2019-2026)

11.2 Global Biologics (Biosimilar) Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Biologics (Biosimilar) Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Biologics (Biosimilar) Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source

List of Tables and Figures

Figure Biologics (Biosimilar) Product Picture

Table Global Biologics (Biosimilar) Production and CAGR (%) Comparison by Type

Table Profile of Recombinant Non-glycosylated Proteins

Table Profile of Recombinant Glycosylated Proteins

Table Biologics (Biosimilar) Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Oncology

Table Profile of Blood Disorders

Table Profile of Growth Hormonal Deficiency

Table Profile of Chronic and Autoimmune Disorders

Table Profile of Others

Figure Global Biologics (Biosimilar) Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Europe Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Germany Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure UK Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure France Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Italy Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Spain Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Russia Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Poland Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure China Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Japan Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure India Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Malaysia Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Singapore Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Philippines Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Indonesia Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Thailand Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Vietnam Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Central and South America Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Brazil Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Mexico Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Colombia Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Turkey Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Egypt Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure South Africa Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Nigeria Biologics (Biosimilar) Revenue and Growth Rate (2014-2026)

Figure Global Biologics (Biosimilar) Production Status and Outlook (2014-2026)

Table Global Biologics (Biosimilar) Production by Player (2014-2019)

Table Global Biologics (Biosimilar) Production Share by Player (2014-2019)

Figure Global Biologics (Biosimilar) Production Share by Player in 2018

Table Biologics (Biosimilar) Revenue by Player (2014-2019)

Table Biologics (Biosimilar) Revenue Market Share by Player (2014-2019)

Table Biologics (Biosimilar) Price by Player (2014-2019)

Table Biologics (Biosimilar) Manufacturing Base Distribution and Sales Area by Player

Table Biologics (Biosimilar) Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table CP Guojian Pharmacy Profile

Table CP Guojian Pharmacy Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Merck Profile

Table Merck Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table 3sbio Profile

Table 3sbio Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Hospira Profile

Table Hospira Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Changchun High tech Profile

Table Changchun High tech Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Pfizer Profile

Table Pfizer Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Mylan Profile

Table Mylan Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Novartis Profile

Table Novartis Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Sandoz Profile

Table Sandoz Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Sanofi Profile

Table Sanofi Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Roche Profile

Table Roche Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Biotech Pharma Profile

Table Biotech Pharma Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Teva Profile

Table Teva Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table AbbVie Profile

Table AbbVie Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Novo Nordisk Profile

Table Novo Nordisk Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Johnson & Johnson Profile

Table Johnson & Johnson Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Lilly Profile

Table Lilly Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Amgen Profile

Table Amgen Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Gelgen Biopharma Profile

Table Gelgen Biopharma Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Biologics (Biosimilar) Production by Type (2014-2019)

Table Global Biologics (Biosimilar) Production Market Share by Type (2014-2019)

Figure Global Biologics (Biosimilar) Production Market Share by Type in 2018

Table Global Biologics (Biosimilar) Revenue by Type (2014-2019)

Table Global Biologics (Biosimilar) Revenue Market Share by Type (2014-2019)

Figure Global Biologics (Biosimilar) Revenue Market Share by Type in 2018

Table Biologics (Biosimilar) Price by Type (2014-2019)

Figure Global Biologics (Biosimilar) Production Growth Rate of Recombinant Non-glycosylated Proteins (2014-2019)

Figure Global Biologics (Biosimilar) Production Growth Rate of Recombinant Glycosylated Proteins (2014-2019)

Table Global Biologics (Biosimilar) Consumption by Application (2014-2019)

Table Global Biologics (Biosimilar) Consumption Market Share by Application (2014-2019)

Table Global Biologics (Biosimilar) Consumption of Oncology (2014-2019)

Table Global Biologics (Biosimilar) Consumption of Blood Disorders (2014-2019)

Table Global Biologics (Biosimilar) Consumption of Growth Hormonal Deficiency (2014-2019)

Table Global Biologics (Biosimilar) Consumption of Chronic and Autoimmune Disorders (2014-2019)

Table Global Biologics (Biosimilar) Consumption of Others (2014-2019)

Table Global Biologics (Biosimilar) Consumption by Region (2014-2019)

Table Global Biologics (Biosimilar) Consumption Market Share by Region (2014-2019)

Table United States Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

Table Europe Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

Table China Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

Table Japan Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

Table India Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

Table Central and South America Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Biologics (Biosimilar) Production, Consumption, Export, Import (2014-2019)

Table Global Biologics (Biosimilar) Production by Region (2014-2019)

Table Global Biologics (Biosimilar) Production Market Share by Region (2014-2019)

Figure Global Biologics (Biosimilar) Production Market Share by Region (2014-2019)

Figure Global Biologics (Biosimilar) Production Market Share by Region in 2018

Table Global Biologics (Biosimilar) Revenue by Region (2014-2019)

Table Global Biologics (Biosimilar) Revenue Market Share by Region (2014-2019)

Figure Global Biologics (Biosimilar) Revenue Market Share by Region (2014-2019)

Figure Global Biologics (Biosimilar) Revenue Market Share by Region in 2018

Table Global Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table China Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table India Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Biologics (Biosimilar) Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Biologics (Biosimilar)

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Biologics (Biosimilar)

Figure Biologics (Biosimilar) Industrial Chain Analysis

Table Raw Materials Sources of Biologics (Biosimilar) Major Players in 2018

Table Downstream Buyers

Figure Global Biologics (Biosimilar) Production and Growth Rate Forecast (2019-2026)

Figure Global Biologics (Biosimilar) Revenue and Growth Rate Forecast (2019-2026)

Figure Global Biologics (Biosimilar) Price and Trend Forecast (2019-2026)

Table United States Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

Table China Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

Table Japan Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

Table India Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

Table Middle East and Africa Biologics (Biosimilar) Production, Consumption, Export and Import Forecast (2019-2026)

Table Global Biologics (Biosimilar) Market Production Forecast, by Type

Table Global Biologics (Biosimilar) Production Volume Market Share Forecast, by Type

Table Global Biologics (Biosimilar) Market Revenue Forecast, by Type

Table Global Biologics (Biosimilar) Revenue Market Share Forecast, by Type

Table Global Biologics (Biosimilar) Price Forecast, by Type

Table Global Biologics (Biosimilar) Market Production Forecast, by Application

Table Global Biologics (Biosimilar) Production Volume Market Share Forecast, by Application

Table Global Biologics (Biosimilar) Market Revenue Forecast, by Application

Table Global Biologics (Biosimilar) Revenue Market Share Forecast, by Application

Table Global Biologics (Biosimilar) Price Forecast, by Application